Skip to Content

Y70 (Rabeprazole sodium delayed-release 20 mg)

Pill with imprint Y70 is Yellow, Round and has been identified as Rabeprazole sodium delayed-release 20 mg. It is supplied by Aurobindo Pharma Limited.

Rabeprazole is used in the treatment of barrett's esophagus; gerd; duodenal ulcer; stomach ulcer; erosive esophagitis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for Y70

Rabeprazole sodium delayed-release

Imprint:
Y70
Strength:
20 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Aurobindo Pharma Limited
National Drug Code (NDC):
65862-0721

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide